Tandem Diabetes Care, Inc. Accounts Receivable, Allowance for Credit Loss, Writeoff
Tandem Diabetes Care, Inc. (TNDM) reported Accounts Receivable, Allowance for Credit Loss, Writeoff of $2.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs · last filed 2026-08-06
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2026-06-30 was $2.27M, a 28.59% decline year-over-year.
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2026-03-31 was $3.59M, a 130.57% increase year-over-year.
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-12-31 was $1.90M, a 27.71% increase year-over-year.
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for the quarter ending 2025-09-30 was $1.71M, a 37.84% decline year-over-year.
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2025 was $8.34M, a 9.31% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2024 was $7.63M, a 53.47% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2023 was $4.97M, a 5.63% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. accounts receivable, allowance for credit loss, writeoff for fiscal 2022 was $4.70M, a 142.35% increase from fiscal 2021.
| Period end | Accounts Receivable, Allowance for Credit Loss, Writeoff 3 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 6 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 9 month | Accounts Receivable, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.27M 10-Q · filed 2026-08-06 | $5.86M 10-Q · filed 2026-08-06 | $7.76M derived: sum of 3 quarters · filed 2026-08-06 | $9.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.59M 10-Q · filed 2026-05-07 | $5.49M derived: sum of 2 quarters · filed 2026-05-07 | $7.19M derived: sum of 3 quarters · filed 2026-05-07 | $10.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.60M derived: sum of 2 quarters · filed 2026-02-19 | $6.78M derived: sum of 3 quarters · filed 2026-08-06 | $8.34M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.71M 10-Q · filed 2025-11-06 | $4.88M derived: sum of 2 quarters · filed 2026-08-06 | $6.44M 10-Q · filed 2025-11-06 | $7.92M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.18M 10-Q · filed 2026-08-06 | $4.73M 10-Q · filed 2026-08-06 | $6.22M derived: sum of 3 quarters · filed 2026-08-06 | $8.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.56M 10-Q · filed 2026-05-07 | $3.04M derived: sum of 2 quarters · filed 2026-05-07 | $5.79M derived: sum of 3 quarters · filed 2026-05-07 | $7.01M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.23M derived: sum of 2 quarters · filed 2026-02-19 | $5.45M derived: sum of 3 quarters · filed 2026-02-19 | $7.63M 10-K · filed 2026-02-19 |
| 2024-09-30 | $2.74M 10-Q · filed 2025-11-06 | $3.97M derived: sum of 2 quarters · filed 2025-11-06 | $6.14M 10-Q · filed 2025-11-06 | $8.07M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.22M 10-Q · filed 2025-08-06 | $3.40M 10-Q · filed 2025-08-06 | $5.33M derived: sum of 3 quarters · filed 2026-02-19 | $6.12M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $2.17M 10-Q · filed 2025-04-30 | $4.10M derived: sum of 2 quarters · filed 2026-02-19 | $4.90M derived: sum of 3 quarters · filed 2026-02-19 | $5.90M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.73M derived: sum of 2 quarters · filed 2026-02-19 | $3.72M derived: sum of 3 quarters · filed 2026-02-19 | $4.97M 10-K · filed 2026-02-19 |
| 2023-09-30 | $795.00K 10-Q · filed 2024-11-06 | $1.79M derived: sum of 2 quarters · filed 2024-11-06 | $3.04M 10-Q · filed 2024-11-06 | $4.81M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $997.00K 10-Q · filed 2024-08-01 | $2.24M 10-Q · filed 2024-08-01 | $4.02M derived: sum of 3 quarters · filed 2025-02-26 | $5.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-02 | $3.02M derived: sum of 2 quarters · filed 2025-02-26 | $4.31M derived: sum of 3 quarters · filed 2025-02-26 | $5.20M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.06M derived: sum of 2 quarters · filed 2025-02-26 | $3.95M derived: sum of 3 quarters · filed 2025-02-26 | $4.70M 10-K · filed 2025-02-26 |
| 2022-09-30 | $1.29M 10-Q · filed 2023-11-01 | $2.18M derived: sum of 2 quarters · filed 2023-11-01 | $2.93M 10-Q · filed 2023-11-01 | $3.35M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $888.00K 10-Q · filed 2023-08-03 | $1.64M 10-Q · filed 2023-08-03 | $2.06M derived: sum of 3 quarters · filed 2024-02-21 | $2.52M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $751.00K 10-Q · filed 2023-05-03 | $1.17M derived: sum of 2 quarters · filed 2024-02-21 | $1.63M derived: sum of 3 quarters · filed 2024-02-21 | $2.25M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $883.00K derived: sum of 2 quarters · filed 2024-02-21 | $1.50M derived: sum of 3 quarters · filed 2024-02-21 | $1.94M 10-K · filed 2024-02-21 |
| 2021-09-30 | $467.00K 10-Q · filed 2022-11-02 | $1.08M derived: sum of 2 quarters · filed 2022-11-02 | $1.52M 10-Q · filed 2022-11-02 | $1.97M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $617.00K 10-Q · filed 2022-08-03 | $1.06M 10-Q · filed 2022-08-03 | $1.50M derived: sum of 3 quarters · filed 2023-02-22 | $1.83M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $441.00K 10-Q · filed 2022-05-04 | $883.00K derived: sum of 2 quarters · filed 2023-02-22 | $1.21M derived: sum of 3 quarters · filed 2023-02-22 | $2.12M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $770.00K derived: sum of 2 quarters · filed 2023-02-22 | $1.68M derived: sum of 3 quarters · filed 2023-02-22 | $2.46M 10-K · filed 2023-02-22 |
| 2020-09-30 | $328.00K 10-Q · filed 2021-11-03 | $1.24M derived: sum of 2 quarters · filed 2021-11-03 | $2.02M 10-Q · filed 2021-11-03 | $2.26M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $911.00K 10-Q · filed 2021-08-04 | $1.69M 10-Q · filed 2021-08-04 | $1.94M derived: sum of 3 quarters · filed 2022-02-22 | $2.11M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $782.00K 10-Q · filed 2021-05-05 | $1.02M derived: sum of 2 quarters · filed 2022-02-22 | $1.20M derived: sum of 3 quarters · filed 2022-02-22 | $1.47M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $415.00K derived: sum of 2 quarters · filed 2022-02-22 | $692.00K derived: sum of 3 quarters · filed 2022-02-22 | $855.00K 10-K · filed 2022-02-22 |
| 2019-09-30 | $173.00K 10-Q · filed 2020-11-05 | $450.00K derived: sum of 2 quarters · filed 2020-11-05 | $613.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $277.00K 10-Q · filed 2020-07-30 | $440.00K 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $163.00K 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | $646.00K 10-K · filed 2021-02-24 | |||
| 2017-12-31 | $524.00K 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $118.00K 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $102.00K 10-K · filed 2018-03-01 | |||
| 2014-12-31 | $153.00K 10-K · filed 2017-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |